AlternativeMed
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic

Alzheimer'S Disease

26
Clinical Trials
35
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00010803
Ginkgo Biloba Prevention Trial in Older Individuals
Completed · Phase 3
NCT00164749
A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease
Completed · Phase 1|Phase 2
NCT00814346
Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions
Completed · Phase 2
📊 Sample Meta-Analyses
CRD42019127560
Saffron for dementia and mild cognitive impairment: a systematic review and meta-analysis of randomized clinical trials
-Dementia (including Alzheimer's disease, vascular disease, Lewy body dementia,
CRD42021275439
A meta-analysis on the association of vitamin B, D, and E levels with the progression and risk of Alzheimer's disease
Alzheimer's Disease, neurodegenerative disease, vitamin deficiency, mitigating r
CRD42021275439
A meta-analysis on the association of vitamin B, D, and E levels with the progression and risk of Alzheimer's disease
Alzheimer's Disease, neurodegenerative disease, vitamin deficiency, mitigating r
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Alzheimer'S Disease
🏥 Names
Disease Name
Alzheimer'S Disease
Alias Names
Alzheimer'S Disease 8; Acute Confusional Senile Dementia; Alzheimer'S Disease 10; Alzheimer'S Disease 6; Alzheimer Disease, Late Onset; Late-Onset Form of Familial Alzheimer Disease; Dementia, Presenile; Alzheimer'S Disease 12; Alzheimer'S Disease; Alzheimer Disease; Alzheimer'S Disease 13; Alzheimer'S Disease 14; Alzheimer'S Disease 1; Alzheimer'S Disease 11; Alzheimer'S Disease 7; Alzheimer'S Disease, Focal Onset; Familial Alzheimer Disease (Fad); Alzheimer'S Disease 5; Alzheimer'S Disease, Un
Topic Type
syndrome
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Disease or Syndrome
MeSH Class
Mental Disorders; Nervous System Diseases
HPO Class
Abnormality of the nervous system
DO Class
disease of anatomical entity; genetic disease
🔗 External References
Disease Ontology
110043; 110045; 110046; 1443; 10
DisGeNET
C0002395
🔍 Raw view — every non-empty column on this row (31 fields)
name
Alzheimer'S Disease
alias name
Alzheimer'S Disease 8; Acute Confusional Senile Dementia; Alzheimer'S Disease 10; Alzheimer'S Disease 6; Alzheimer Disease, Late Onset; Late-Onset Form of Familial Alzheimer Disease; Dementia, Presenile; Alzheimer'S Disease 12; Alzheimer'S Disease; Alzheimer Disease; Alzheimer'S Disease 13; Alzheimer'S Disease 14; Alzheimer'S Disease 1; Alzheimer'S Disease 11; Alzheimer'S Disease 7; Alzheimer'S Disease, Focal Onset; Familial Alzheimer Disease (Fad); Alzheimer'S Disease 5; Alzheimer'S Disease, Unspecified; Alzheimer'S Disease 2; Presenile And Senile Dementia; Alzheimer Disease, Early Onset; Cer
topic type
syndrome
disgenet disease type
disease
umls disease type
Disease or Syndrome
mesh disease class
Mental Disorders; Nervous System Diseases
hpo disease class
Abnormality of the nervous system
do disease class
disease of anatomical entity; genetic disease
umls disease type id
T047
mesh disease class id
F03; C10
hpo disease class id
HP:0000707
do disease class id
DOID:7; DOID:630
herb disease id
HBDIS000117
disgenet id
C0002395
mesh id
D000544
hpo id
HP:0002511
do id
110043; 110045; 110046; 1443; 10
icd10 id
G30.9; G30
omim id
104300

🌿 Related Herbs

2 · shared evidence

📋 Clinical Trials

12 · subject of clinical study
NCT00010803 Ginkgo Biloba Prevention Trial in Older Individuals
→ Dementia|Alzheimer's Disease
NCT00164749 A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease
→ Alzheimer's Disease
NCT00814346 Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined
→ Alzheimer's Disease|Cognitive Impairment
NCT00391833 Effect of Panax Ginseng on the Cognitive Performance in Alzheimer's Disease
→ Alzheimer's Disease|Memory Decline
NCT00164749 A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease
→ Alzheimer's Disease
NCT00689637 Drug Interaction Study Between AZD3480 and Warfarin
→ Alzheimer's Disease
NCT00099710 Curcumin in Patients With Mild to Moderate Alzheimer's Disease
→ Alzheimer's Disease
NCT00082602 Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer'
→ Alzheimer's Disease
NCT00309725 A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.
→ Alzheimer's Disease
NCT00814801 An Efficacy and Safety Study of Galantamine for the Treatment of Patients With A
→ Alzheimer's Disease
NCT01054976 The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's
→ Alzheimer's Disease
NCT01478633 Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Al
→ Alzheimer's Disease

📊 Meta-Analyses

12 · systematic review
CRD42019127560 Saffron for dementia and mild cognitive impairment: a systematic review and meta
→ -Dementia (including Alzheimer's disease, vascular
CRD42021275439 A meta-analysis on the association of vitamin B, D, and E levels with the progre
→ Alzheimer's Disease, neurodegenerative disease, vi
CRD42021275439 A meta-analysis on the association of vitamin B, D, and E levels with the progre
→ Alzheimer's Disease, neurodegenerative disease, vi
CRD42020210179 Efficacy of butylphthalide combined with oxiracetam in the treatment of vascular
→ Vascular cognitive impairment is the second most c
CRD42021268819 What is new about the relationship between copper dyshomeostasis and Alzheimer’s
→ Relationship between copper and Parkinson's or cop
CRD42021283692 The potential diagnostic accuracy of endogenous formaldehyde in Alzheimer's
→ Alzheimer's disease (AD) is a neurodegenerative di
CRD42018109231 Donepezil, galantamine, rivastigmine and memantine for Alzheimer's disease:
→ Alzheimer's disease.
CRD42015024796 Huperzine A for major depressive disorder: a review of the literature
→ Huperzine A, an alkaloid initially identified from
CRD42015024796 Huperzine A for major depressive disorder: a review of the literature
→ Huperzine A, an alkaloid initially identified from
CRD42015024796 Huperzine A for major depressive disorder: a review of the literature
→ Huperzine A, an alkaloid initially identified from
CRD42015024198 Huperzine A for cognitive deficits in schizophrenia: a systematic review and met
→ Huperzine A, an alkaloid initially identified from
CRD42015024198 Huperzine A for cognitive deficits in schizophrenia: a systematic review and met
→ Huperzine A, an alkaloid initially identified from
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: empty — needs HERB_herb_ingredient import
  • Ingredient ↔ Target: empty — needs HERB_ingredient_target import
  • Target ↔ Disease: empty — needs HERB_target_disease import
  • Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables